ReviewResearch and practice in thrombosis and haemostasis2020

Fibrinolytic therapy for refractory COVID-19 acute respiratory distress syndrome: Scientific rationale and review.

Christopher D Barrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.